Metraipolis › archive › dc_4d9dde90fb04
A novel effect of bevacizumab in reducing characteristic pigmentation in Peutz-Jeghers syndrome: a case report and literature review — Europe PMC PMID:41573642
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41573642
- DOI
- 10.3389/fonc.2025.1694187
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T00:38:34.812Z
- SHA-256 of the archived text
a298d7f278a58426a91f79ca4df4abe6ece9b0322f387bf794d4e28d6bc00e67- Stable URL of this page
https://metraipolis.com/documento/dc_4d9dde90fb04
How to cite
A novel effect of bevacizumab in reducing characteristic pigmentation in Peutz-Jeghers syndrome: a case report and literature review — Europe PMC PMID:41573642 — Europe PMC (en), https://europepmc.org/article/MED/41573642 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4d9dde90fb04 (Metraipolis archive dc_4d9dde90fb04, sha256 a298d7f278a58426a91f79ca4df4abe6ece9b0322f387bf794d4e28d6bc00e67)
BibTeX
@misc{dc4d9dde90fb04,
title = {A novel effect of bevacizumab in reducing characteristic pigmentation in Peutz-Jeghers syndrome: a case report and literature review — Europe PMC PMID:41573642},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41573642},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4d9dde90fb04; sha256 a298d7f278a58426a91f79ca4df4abe6ece9b0322f387bf794d4e28d6bc00e67},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41573642. Agents can read the archived copy with the MCP tool read_document.